Rakuten Investment Management Inc. Buys 1,480 Shares of HCA Healthcare, Inc. $HCA

Rakuten Investment Management Inc. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,949 shares of the company’s stock after acquiring an additional 1,480 shares during the quarter. Rakuten Investment Management Inc.’s holdings in HCA Healthcare were worth $11,632,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in HCA. Markel Group Inc. grew its holdings in HCA Healthcare by 0.7% during the third quarter. Markel Group Inc. now owns 84,972 shares of the company’s stock valued at $36,261,000 after purchasing an additional 606 shares during the last quarter. Provenance Wealth Advisors LLC lifted its stake in shares of HCA Healthcare by 1,260.0% in the third quarter. Provenance Wealth Advisors LLC now owns 136 shares of the company’s stock worth $58,000 after buying an additional 126 shares during the last quarter. Evergreen Private Wealth LLC boosted its holdings in shares of HCA Healthcare by 5.9% during the 3rd quarter. Evergreen Private Wealth LLC now owns 11,671 shares of the company’s stock worth $4,980,000 after buying an additional 650 shares during the period. Factory Mutual Insurance Co. acquired a new position in HCA Healthcare in the 3rd quarter valued at $1,559,000. Finally, GRIMES & Co WEALTH MANAGEMENT LLC bought a new position in HCA Healthcare in the 3rd quarter worth $215,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 10.3%

Shares of HCA stock opened at $510.31 on Thursday. The stock has a 50 day moving average of $440.51 and a two-hundred day moving average of $444.90. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The company has a market capitalization of $106.60 billion, a P/E ratio of 16.91, a P/E/G ratio of 1.55 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business had revenue of $19.85 billion for the quarter, compared to analysts’ expectations of $19.33 billion. During the same period in the previous year, the business posted $6.96 earnings per share. HCA Healthcare’s quarterly revenue was up 3.6% on a year-over-year basis. Sell-side analysts predict that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.34%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on HCA. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Barclays lifted their price objective on HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 29th. TD Cowen boosted their price objective on HCA Healthcare from $460.00 to $486.00 and gave the stock a “buy” rating in a research report on Wednesday, October 28th. Weiss Ratings upgraded HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Finally, The Goldman Sachs Group lowered their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $480.13.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Hospitals and health insurers rallied after Democrats’ midterm gains, a sector-wide move that likely helped lift HCA. The coverage does not specify which policy changes investors expect. Article: Health insurers, hospitals rally after sweeping midterm win for Democrats
• Positive Sentiment: HCA’s quarterly results beat expectations: adjusted earnings were $7.22 per share versus a $6.65 consensus estimate, and revenue was $19.85 billion versus $19.33 billion. Revenue grew 3.6% year over year. Article: Why HCA Healthcare is a top growth stock for the long term
• Positive Sentiment: Wells Fargo raised its price target on HCA, while Truist reaffirmed its Buy rating and lifted its target to $510 from $495. These moves signal continued analyst support. Article: HCA Healthcare stock gets price target boost from Wells Fargo Article: Truist reaffirms Buy rating
• Positive Sentiment: HCA Houston Healthcare Northwest introduced next-generation robotic-assisted surgical technology, which may strengthen its service offering and competitive position. Article: HCA Houston Healthcare Northwest introduces robotic-assisted surgical technology
• Neutral Sentiment: HCA is planning a $300 million hospital in Cape Coral, with $31 million in city incentives. The project supports expansion, though its investment and execution costs may take time to translate into returns. Article: Cape Coral lands $300 million HCA hospital
• Neutral Sentiment: HCA launched a senior-notes offering; the article listing does not provide details on terms or intended use of proceeds, so the effect on leverage is unclear. Article: HCA Healthcare launches senior notes offering
• Negative Sentiment: Uninsured-patient costs reportedly shifted by $400 million in HCA’s third-quarter payer mix, a potential headwind to profitability. Article: HCA Q3 revenue by payer as uninsured shift costs $400M
• Negative Sentiment: Reports of data breaches involving HCA raise potential privacy, regulatory, and reputational concerns; the article listing does not specify the impact. Article: Data breaches announced by HCA Healthcare
• Negative Sentiment: A law firm announced an investigation into claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but it can create legal and reputational uncertainty. Article: Pomerantz investigates claims on behalf of HCA investors

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.